April 28, 2023
BioPharma has experienced significant growth in recent years. This report by Robert Stoner and Jéssica Dutra, prepared for Pfizer, on the BioPharma Economic Impact in the US Economy demonstrates that the BioPharma industry in the United States provides significant value added to the GDP, a significant “multiplier” effect on employment and earnings, and a major R&D presence in the United States and worldwide.
Secretariat Client Natera Wins Preliminary Injunction against NeoGenomics
Economic analysis performed by Dr. Anup Malani and the Secretariat team demonstrates that a preliminary injunction is warranted. Natera, Inc., which specializes in cell-free DNA testing technology, sought a preliminary injunction against competitor NeoGenomics Laboratories, Inc.
Recursive Nash-in-Nash Bargaining Solution
Keith Waeher authored the paper “Recursive Nash-in-Nash Bargaining Solution” with Xiaowei Yu. The paper has been published in Economics Bulletin.
The Dawning of Diverse Data: How eDiscovery Is Moving Beyond Emails
Gone are the days when email reigned supreme in eDiscovery. The digital landscape is evolving rapidly and, within the next two years, diverse digital data will surpass email in prevalence. This shift will significantly impact legal reviews, demanding new approaches and adaptations. Let’s explore the rise of diverse data, its implications for eDiscovery, and how […]